About AnaPath
AnaPath is a company based in Liestal (Switzerland) founded in 2005. It operates as a B2B and Service Contracts. AnaPath has completed 1 acquisition, including Envigo. AnaPath offers products and services including Histotechnology, Histopathology, Necropsy Services, Molecular Pathology, and Special Technologies. AnaPath operates in a competitive market with competitors including Celgene, Medelis WCCT Global, Syneos Health, Emmes and Parexel, among others.
- Headquarter Liestal, Switzerland
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Anapath Services Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AnaPath
AnaPath offers a comprehensive portfolio of products and services, including Histotechnology, Histopathology, Necropsy Services, Molecular Pathology, and Special Technologies.
Processes and stains tissues for microscopic analysis.
Analyzes tissue samples for disease and toxicity.
Conducts postmortem examinations for research purposes.
Performs molecular tests for genetic and disease markers.
Utilizes electron microscopy and confocal imaging tools.
People of AnaPath
Unlock access to complete
Funding Insights of AnaPath
Detailed funding history for AnaPath
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AnaPath
AnaPath has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Envigo.
Investment portfolio details for AnaPath
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Drug discovery and development services are provided using research models.
|
Locked | Locked | 2015 | Locked |
Complete acquisition details for AnaPath
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - AnaPath
Detailed financials for AnaPath
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Anapath Comparisons
Peer comparison for AnaPath
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AnaPath
AnaPath operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celgene, Medelis WCCT Global, Syneos Health, Emmes and Parexel, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapies for cancer and inflammatory diseases are developed.
|
|
| Locked | Locked | Locked |
Full-service CRO expertise in influenza and oncology research is offered.
|
|
| Locked | Locked | Locked |
CRO clinical development services are provided by Syneos Health.
|
|
| Locked | Locked | Locked |
Outsourced contract research organization services are provided to clients.
|
|
| Locked | Locked | Locked |
Full-service clinical research organization services are provided globally by Parexel.
|
|
| Locked | Locked | Locked |
Global full-service CRO services are delivered in over 80 countries.
|
Detailed competitors of AnaPath
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Anapath
Complete news archive for AnaPath
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AnaPath
AnaPath was founded in 2005.
AnaPath is headquartered in Liestal, Switzerland. It is registered at Liestal, Basel-landschaft, Switzerland.
AnaPath Services GmbH is a contract research organization focused on histopathology, offering services like tissue processing, histopathology analysis, necropsy, molecular pathology, and special technologies such as electron microscopy. Based in Liestal, Switzerland, with sites in Spain and Korea, it serves pharmaceutical and research clients by conducting in vivo safety assessments and providing high-quality, GLP-certified solutions to meet project needs.
AnaPath's top competitors include Emmes, Syneos Health and ClinChoice.
AnaPath offers Histotechnology, Histopathology, Necropsy Services, Molecular Pathology, and Special Technologies.
AnaPath has made 1 acquisition, including Envigo.